ACID REFLUX DRUG LAWSUIT STATUS:: Product liability lawyers are reviewing potential Nexium lawsuits, Prilosec lawsuits and other claims involving side effects of acid reflux drugs known as proton pump inhibitors (PPI). Potential claims are being reviewed for users who suffered any of the following injuries:
Nexium, Prilosec and Other Acid Reflux Drug Lawsuits. Other recent studies have linked PPIs to an increased risk of gastric lesions and pancreatic cancer. In August 2017, all PPI injury lawsuits were consolidated for pretrial proceedings as part of an MDL, or multidistrict litigation, in New Jersey federal court.
As a result of the drug makers’ failure to warn about the link between acid reflux drugs and kidney problems, financial compensation may be available for users of any of the following proton pump inhibitors:
Filing an antacid lawsuit is the only means to obtain compensation for suffering, damage, medical expenses and loss related to cancer caused by acid reflux medicine.
Based on prior settlements, we think Zantac cases in the highest settlement tiers (plaintiffs with the most types of cancer and longest use history) could get settlement payouts of around $300,000-$400,000. Second-tier cases could see Zantac lawsuit settlement amounts in the $100,000-$175,000 range.
Colorado resident Mark Allan Blake filed his Zantac lawsuit against Sanofi US Services Inc., Chattem Inc., Boehringer Ingelheim, Pfizer and GlaxoSmithKline on Oct. 21, 2019. Blake started taking prescription Zantac in 1996. He then switched to Zantac OTC which he took four times a week.
Current Zantac lawsuits are still pending, but it is expected that plaintiffs will reach a settlement with the drug manufacturers within the next several years. There are more than a dozen drug makers that produce heartburn drug Zantac and generic ranitidine medications.
Now, people who bought it off retail shelves are concerned it could could cause cancer (including a cancer diagnosis of stomach cancer, kidney cancer, prostate cancer, bladder cancer, brain cancer, or other side effects) due to high NDMA levels in the over the counter Zantac and its generic ranitidine alternative.
First, to potentially qualify for a Zantac cancer lawsuit or settlement, you have to prove use. That means that you have to show that you took Zantac (or another form of ranitidine). If you took prescription ranitidine, this can be easily proven by asking for a copy of your pharmacy records.
You may be able to file a civil lawsuit against the manufacturer of Zantac or another medication that includes ranitidine as an ingredient if you qualify.
Popular heartburn medication returns to market with new name - Zantac 360°™ - and new active ingredient. In April 2021, Sanofi Consumer Healthcare released a new, over-the counter (OTC) medication called Zantac 360°.
An increasing number of proton pump inhibitor lawsuits are being filed against the drug makers. The lawsuits allege that the manufacturer of omeprazole and other PPIs have failed to provide important safety information regarding serious complications such as chronic kidney disease and kidney failure.
The ranitidine lawsuits are not part of a class action. Instead, these are individual lawsuits of the victim against the drugmaker. Many of the claims will join into a multidistrict litigation (MDL). This will expedite the litigation and settlement process.
Tennessee Zantac cancer lawsuits allege the manufacturer knew or should have known about the dangers of its product. In addition, Tennessee Zantac lawyers accused the antacids manufacturer of negligently allowing generic versions of the medication to be used in the FDA marketplace.
Tennessee Zantac lawsuits have been filed pertaining to the active ingredient ranitidine. It is alleged this medication delivered high levels of the NDMA carcinogen into the human body. TN Ranitidine attorneys have attributed this to instability of the drug molecules.
The pharmaceutical company Sanofi-Aventis U.S. LLC has been named as a defendant in this litigation. The limited liability company is an American subsidiary of the French parent company Sanofi. Together with other Sanofi affiliates, they controlled production and distribution of Zantac in the United States.
If you or a loved one in Tennessee developed Liver, Bladder, Colorectal, Prostate, Esophageal/Throat/Nasal, Stomach, Brain, Kidney (Renal), Pancreatic, Lung, Testicular, Breast, Non-Hodgkin Lymphoma, Mouth, Small Intestine, Large Intestine, Anal, Gallbladder, Appendix or Cecum cancer after taking medication for acid reflux or heartburn, you may be eligible to file an antacid cancer lawsuit in Tennessee.
This page contains answers to common questions regarding Zantac and other antacid cancer lawsuits in Tennessee, including a list of drugs subject to recall and information on legal fees. This information has been compiled by our attorneys handling antacid cancer lawsuits in Tennessee.
Residents of Tennessee are becoming incresingly aware that heartburn and acid reflux medicines such as Prilosec, Zantac, Prevacid, Nexium and generic Zantac have been found to cause cancer. Available by prescription and over-the-counter in Tennessee and nationwide, antacids are used daily by millions of Americans.
Millions of Americans suffer from heartburn and acid reflux. Over-the-counter and prescription drugs like Nexium and Prilosec offer some relief, but recent evidence shows they are associated with severe, life-threatening side effects. Many Americans are discovering their kidney disease and other health problems are linked to heartburn drugs like Nexium and Prilosec. If you are among them, don’t hesitate to get legal help from a skilled Chicago dangerous drug attorney at Pintas & Mullins Law Firm. With over 50 years of collective experience and over 10,000 cases handled, we have the insight and resources necessary to pursue just compensation in dangerous drug cases.
Several studies now link these drugs to significant risks for chronic kidney disease and failure, causing shock and worry among patients and doctors alike.
The class of medications includes some of the most widely used drugs in the United States, with brand-name, generic and over-the-counter versions of Nexium, Prilosec and other drugs generating over $14 billion in annual sales. The medications have been aggressively promoted as safe and effective, suggesting that users face little risk ...
The FDA required an update to the warning label about the risk of fractures from Nexium and other drugs in the class. FDA investigators determined that the risk of fractures is dose-specific and have not applied the Nexium bone fracture warning requirements to the over-the-counter versions of Nexium or similar PPIs.
The study found that there was a 45% increased risk of chronic kidney disease with proton pump inhibitors (PPI). Another study, presented at a conference in November 2017, warned that PPIs appear to increase the risk of chronic kidney disease and kidney failure by one-third.
Elderly users were found to be more likely to suffer acute kidney injury on Nexium, Prilosec or another PPI, when compared to users who were not taking the drug. Similarly, the risk of acute interstitial nephritis from the acid reflux drugs was tripled for those users.
The medications have been aggressively promoted as safe and effective, suggesting that users face little risk of side effects from Nexium, Prilosec or other acid reflux drugs. However, a number of studies have suggested that users may face a potential risk of kidney injury, kidney disease or kidney failure. In December 2014, the FDA required new ...
Side effects of Nexium, Prilosec and other blockbuster heartburn and acid reflux medications have been linked to a number of serious risks, including kidney damage and stomach cancer. Cases are being pursued over failure to adequately warn users and the medical community about these potential risks.
A day later, a study published in the medical journal Gut by researchers from Hong Kong warned that drugs like Nexium and Prilosec doubled the risk of gastric cancer.
Acid reflux disease affects people of all ages, ethnicities, and demographics. Acid reflux disease may also be referred to as gastroesophageal reflux disease, sometimes shortened as GERD. A joint study by Johns Hopkins Hospital and Homestead Hospital estimates that as many as 1 in 5 adults, or 20%, are affected by a form of GERD.
If you are suffering from any of the following symptoms, you could be experiencing acid reflux disease (GERD):
A doctor or medical specialist should oversee the treatment of GERD. Treatment for this condition generally encompasses a change in lifestyle, prescription of medication, or a combination of both.
Ranitidine is a common drug prescribed to those who are diagnosed with acid reflux disease and is commercially known as Zantac. As of 2020, the FDA recalled Zantac due to the presence of a potentially harmful chemical compound known as NDMA. NDMA can be toxic to human beings and some studies suggest it can cause cancer.
If you or someone you love were prescribed potentially dangerous medication, such as ranitidine, for your acid reflux disease, you may be able to take legal action. Taking ranitidine can be dangerous and have long-term effects on your health. In some cases, those who were prescribed ranitidine may be eligible for financial compensation.
Zantac, generically known as ranitidine, has been on all our shelves as a medicine for heartburn, stomach pain, indigestion, and other gastrointestinal problems. It has been prescribed and sold over-the-counter (OTC) for stomach complaints ranging from acid reflux to ulcers.
Fill out the form below for a fast and FREE review of your case, and get the best options for getting the help you need now!
In the case of Zantac, ranitidine, Prilosec, Prevacid and Nexium, manufacturers failed to warn federal regulators or the public of the antacid cancer risk for several decades.
Cancer from heartburn medicines is the subject of ongoing FDA investigation, and many of these products are now subject to acid reflux drug recalls or have been pulled off the shelf in major drug stores including CVS, Walgreens, Walmart and Rite Aid.
Heartburn Medicine Cancer. Among the most widely-used drugs in the nation, heartburn medicines are now known to cause cancer. Compiled by attorneys for antacid cancer cases, this page contains full information on antacid recalls, FDA acid reflux medicine cancer warnings and heartburn drug cancer research.
Prilosec is another over-the-counter acid reflux medication linked to kidney disease, renal disease and stomach / gastric cancers. Prilosec lawsuits claim the manufacturer and distributor of this product failed to warn consumers of the long term health risks of their product.
Nexium lawsuits allege the manufacturer of this product failed to provide proper warning to patients of the risks associated with Nexium. Millions of people take Nexium or similar medications on a regular basis.
Nexium belongs to a class of drugs called proton pump inhibitors (PPIs), which turn off the “acid pumps” in the stomach and block the production of acid. Common Proton Pump Inhibitors (Brand Name and Generic Name): Dexilant (Dexlansoprazole) Nexium (Esomeprazole)
Protonix (Pantoprazole) AcipHex (Rabeprazole) The Food and Drug Administration (FDA) approved esomeprazole in 2001. Pfizer bought the rights to the over-the-counter version of Nexium from AstraZeneca in 2012.
FDA Bone Fracture Warning. In May 2010, the FDA warned that there may be increased risk of bone fracture of the hip, wrist, and spine from prescription strength acid reflux drugs like Nexium. The FDA required an update to the warning label about the risk of fractures from Nexium and other drugs in the class.
Nexium relieves heartburn, difficulty swallowing, and persistent cough caused by acid reflux. It also helps heal acid damage to the stomach and esophagus, prevents ulcers, and may help prevent cancer in the esophagus. Nexium belongs to a class of drugs called proton pump inhibitors (PPIs), which turn off the “acid pumps” in ...
A study suggests that taking Nexium and other proton pump inhibitors may increase a person’s risk for kidney failure and kidney disease. April 2015. A study suggests that long-term use of Nexium and other PPIs may be linked to an increased risk of nephritis or kidney inflammation and injury. December 2014.
Nexium Lawsuit. A Nexium lawsuit may be an option for patients who suffered complications after taking the heartburn medication for acid reflux disease. Complications such as chronic kidney disease, bone fractures, kidney failure, and hypomagnesemia have been linked to Nexium, one of the leading drugs on the market, and other proton pump inhibitors.
However, in May 2010, the FDA announced that due to the strong association between PPIs and various types of bone fractures, the packaging on these type of drugs, including Nexium, would be required to carry an enhanced warning regarding the risks of these side effects.